Replicons of a rodent hepatitis C model virus permit selection of highly permissive cells

Keyphrases

• Rodents 100%
• Hepatitis C Model 100%
• Replicon 100%
• Rodent Hepaciviruses 100%
• Model Virus 100%
• Permissive Cells 100%
• Hepatitis C Virus 35%
• NS5A 17%
• In Vitro System 17%
• Virus-host Interactions 17%
• Hepatitis C Virus Infection 11%
• Cell Clones 11%
• Virus Life Cycle 11%
• Laboratory Mice 11%
• Immunodeficient Mice 11%
• Replica Method 11%
• Molecular Virology 11%
• MiR-122 11%
• NS3/4A Protease 11%
• Reporter Gene 11%
• Tropism 11%
• Surrogate Model 5%
• Virus 5%
• Hepatitis C Virus Replication 5%
• Mouse Liver 5%
• High Concentration 5%
• Immunization 5%
• Animal Experiment 5%
• Hepatitis C 5%
• Laboratory Animals 5%
• Vaccine Development 5%
• Hepatitis 5%
• Molecular Characterization 5%
• Hepacivirus 5%
• Culture System 5%
• Experimental Infection 5%
• Reverse Genetics 5%
• Virus Replication 5%
• Host Factors 5%
• Polymerase Inhibitors 5%
• Virus-like 5%
• NS4B 5%
• NS5B 5%
• Subgenomic Replicon 5%
• Rattus Norvegicus 5%
• Steatosis 5%
• Sofosbuvir 5%
• Infection Genetics 5%
• Rat Liver 5%
• Mitochondrial Antiviral Signaling Protein 5%
• Miravirsen 5%
• Human Liver Diseases 5%
• Global Control 5%
• Acquired mutations 5%
• Virus Polymerase 5%
• Bicistronic 5%
• UpA Dinucleotide 5%
• Replicon-RNA 5%
• In Vivo System 5%

Immunology and Microbiology

• Hepatitis C 100%
• Hepacivirus 100%
• Replicon 100%
• Permissive Cells 100%
• Hepatitis C Virus 42%
• NS5A 15%
• Life Cycle 15%
• Vaccine Efficacy 10%
• Viral Replication 10%
• Cell Clone 10%
• Reporter Gene 10%
• Molecular Virology 10%
• Virus Cell Interaction 10%
• Infectious Agent 5%
• Animal Experiment 5%
• Mouse 5%
• Experimental Mouse 5%
• Experimental Rat 5%
• Experimental Animal 5%
• Host Factor 5%
• Rattus norvegicus 5%
• NS5B 5%
• NS4B 5%
• Sofosbuvir 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Hepatitis C 100%
• Hepacivirus 100%
• Hepatitis C Virus 42%
• Antivirus Agent 15%
• Chronicity 10%
• microRNA 122 10%
• Infectious Agent 5%
• Mouse 5%
• Infection 5%
• Liver Disease 5%
• Proteinase Inhibitor 5%
• Experimental Animal 5%
• Experimental Rat 5%
• Vaccine Development 5%
• Miravirsen 5%
• Experimental Infection 5%
• Hepacivirin 5%
• Host Factor 5%
• Rattus norvegicus 5%
• Steatosis 5%
• Sofosbuvir 5%
• Dinucleotide 5%
• Experimental Mouse 5%